Kabra Drugs Ltd
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 |
|---|---|---|---|
| Revenue | 46.29 | 35.52 | 30.60 |
| Operating Expense | 43.43 | 34.07 | 27.99 |
| Net Profit | 2.12 | 1.06 | 2.57 |
| Net Profit Margin | 4.58% | 2.98% | 8.40% |
| Earning Per Share | 0.90 | 0.45 | 1.08 |
| EBIDTA | 2.87 | 1.45 | 2.61 |
| Effective Tax Rate | 25.09% | 24.83% | 1.15% |
Particulars
Jun 2026
Revenue46.29
Operating Expense43.43
Net Profit2.12
Net Profit Margin4.58
Earning Per Share0.90
EBIDTA2.87
Effective Tax Rate25.09
